D. A. Koryagina
Research Subjects
Research Interests
D. A. Koryagina has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Evgeny Dmitrievich Kasyanov
V.M. Bekhterev National Medical Research Centre for Psychiatry and Neurology
3 shared publications - Galina Elevna Mazo
Department of Social neuropsychiatry V. M. Bekhterev National Medical Research Center for Psychiatry and Neurology Saint-Petersburg Russia
3 shared publications - Aleksander G. Sofronov
North-Western State Medical University Named After I.I. Mechnikov
1 shared publication - Aleksandr P. Kotsyubinsky
V.M. Bekhterev National Medical Research Centre for Psychiatry and Neurology
1 shared publication - Arslan Moritz
St. Petersburg State University
1 shared publication D. M. Ivashinenko
N.P. Kamenev Tula Regional Clinical Hospital No. 1
1 shared publication
Latest Publications
- 5 October 2026
- Published by Mental Health Research Institute in Сибирский вестник психиатрии и наркологии
- No. 3(132)
Sex is not a covariate: an umbrella review of sex-specific differences in mood disorders
- 5 October 2026
- Published by Mental Health Research Institute in Сибирский вестник психиатрии и наркологии
- No. 3(132)
Sex is not a covariate: an umbrella review of sex-specific differences in mood disorders
- Open Access
- 7 September 2026
- Published by V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology in V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY
- Vol. 60 (4) , 65-80
The Anhedonia Phenomenon in the Mirror of Clinical Experience: Results of a Survey of 1,021 Psychiatrists in Russia
Objective. To comprehensively assess practicing psychiatrists’ clinical views, diagnostic practices, and therapeutic approaches to anhedonia in the Russian Federation. Materials and methods. A crosssectional survey was conducted from March to September 2025. A purpose-designed 27-item questionnaire covered detection and clinical significance of anhedonia, its impact on prognosis, and pharmacological and psychotherapeutic strategies. Eligible participants were physicians actively practicing psychiatry in the Russian Federation. The sample was recruited via targeted mailings to institutional clusters with subsequent link forwarding (i.e., elements of snowball sampling); the final cohort represents a purposive sample. Statistical analyses were performed in R 4.2.1 using base R and the psych package. Results . A total of 1,021 physicians were included (mean age 40.8 years [SD 11.3]; years in practice 14.5 [SD 10.9]). Nearly all respondents explicitly assess anhedonia in depression (96.5%). In clinicians’ subjective estimates, anhedonia occurs in 40–80% of patients and is most pronounced in melancholic depression (55.6%). The transdiagnostic nature of anhedonia is acknowledged by most respondents (77.1%), most often in the context of schizophrenia/schizoaffective disorder and bipolar disorder. Anhedonia is viewed as a marker of unfavorable prognosis: impaired functioning (62.2%), slower improvement (59.5%), and increased suicide risk (51.8%). Consensus regarding psychotherapy was high (81.1%; cognitive behavioral therapy most frequently cited). Opinions on pharmacotherapy were divided: 52.0% considered some antidepressants more effective in pronounced anhedonia; the need for antipsychotics was more often not supported (56.9%). No substantial geographic differences between metropolitan areas and other regions were identified. Male physicians were somewhat less likely to endorse the necessity of psychotherapy for anhedonia. About half of the respondents noted that under antidepressant treatment, worsening or persistence of anhedonia was often accompanied by “emotional blunting” (feelings of flattened emotions, apathy) in patients. Conclusions . Russian psychiatrists regard anhedonia as a central and transdiagnostic symptom that affects prognosis and warrants proactive assessment. These findings support domain-oriented approaches to anhedonia and personalized algorithms for managing patients with depression.
- 7 September 2026
- Published by V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology in V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY
- Vol. 60 (4) , 65-80
Open AccessThe Anhedonia Phenomenon in the Mirror of Clinical Experience: Results of a Survey of 1,021 Psychiatrists in Russia
Objective. To comprehensively assess practicing psychiatrists’ clinical views, diagnostic practices, and therapeutic approaches to anhedonia in the Russian Federation. Materials and methods. A crosssectional survey was conducted from March to September 2025. A purpose-designed 27-item questionnaire covered detection and clinical significance of anhedonia, its impact on prognosis, and pharmacological and psychotherapeutic strategies. Eligible participants were physicians actively practicing psychiatry in the Russian Federation. The sample was recruited via targeted mailings to institutional clusters with subsequent link forwarding (i.e., elements of snowball sampling); the final cohort represents a purposive sample. Statistical analyses were performed in R 4.2.1 using base R and the psych package. Results . A total of 1,021 physicians were included (mean age 40.8 years [SD 11.3]; years in practice 14.5 [SD 10.9]). Nearly all respondents explicitly assess anhedonia in depression (96.5%). In clinicians’ subjective estimates, anhedonia occurs in 40–80% of patients and is most pronounced in melancholic depression (55.6%). The transdiagnostic nature of anhedonia is acknowledged by most respondents (77.1%), most often in the context of schizophrenia/schizoaffective disorder and bipolar disorder. Anhedonia is viewed as a marker of unfavorable prognosis: impaired functioning (62.2%), slower improvement (59.5%), and increased suicide risk (51.8%). Consensus regarding psychotherapy was high (81.1%; cognitive behavioral therapy most frequently cited). Opinions on pharmacotherapy were divided: 52.0% considered some antidepressants more effective in pronounced anhedonia; the need for antipsychotics was more often not supported (56.9%). No substantial geographic differences between metropolitan areas and other regions were identified. Male physicians were somewhat less likely to endorse the necessity of psychotherapy for anhedonia. About half of the respondents noted that under antidepressant treatment, worsening or persistence of anhedonia was often accompanied by “emotional blunting” (feelings of flattened emotions, apathy) in patients. Conclusions . Russian psychiatrists regard anhedonia as a central and transdiagnostic symptom that affects prognosis and warrants proactive assessment. These findings support domain-oriented approaches to anhedonia and personalized algorithms for managing patients with depression.